drugset / Trial / NCT05013164

Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder

NCT05013164 ↗

Phase 2 Completed 44 enrolled Nishtar Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

No such study has been conducted in Pakistan so the primary objective of this study was to determine the role of folinic acid in improving the speech and adaptive skills while secondary objective was improvement of stereotype movements and hyperactivity in ASD among children aged 3 to 14 years.

Timeline

Start
2020-10-01
Primary completion
2021-03-30
Completion
2021-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule 2 mg/kg —